[The anti-hepatotoxic effect of aliphatic and heterocyclic mercapto compounds in CCl4-induced liver damage in the rat. I].
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002251:Carbon Tetrachloride / Q000037:antagonists & inhibitors; D002252:Carbon Tetrachloride Poisoning / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology / Q000517:prevention & control; D002802:Cholinesterases / Q000097:blood; D003545:Cysteine / Q000627:therapeutic use; D006710:Homocysteine / Q000627:therapeutic use; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D051381:Rats; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D013438:Sulfhydryl Compounds; D006710:Homocysteine; D002251:Carbon Tetrachloride; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D002802:Cholinesterases; D000469:Alkaline Phosphatase; D010396:Penicillamine; D003545:Cysteine
Die antihepatotoxische Wirkung aliphatischer und heterozyklischer Mercaptoverbindungen bei der Leberschädigung der Ratte durch CCl4.